«More than two million people are diagnosed with breast cancer globally each year, but a shortage of available specialists can place stress on screening systems, hampering access and accuracy — especially in underserved regions and countries that require double-reading for mammography.»

«In a blog post on the deal — Google Health’s first with a mammography AI vendor — Google and iCAD argue that linking iCAD’s portfolio of breast imaging tools with Google Health’s mammography AI tech will help radiologists arrive at diagnoses quickly and more accurately.»

«Under the definitive agreement, Google has licensed its AI technology for breast cancer and personalized risk assessment to iCAD. iCAD will use the tech to improve its 3D and 2D AI algorithms and commercialize developed products, such as clinical decision support for short-term breast cancer risk, the company said in a release.»

Article written by Rebecca Pifer



Health Care Dive